You are using an older browser version. Please use a supported version for the best MSN experience.

FDA approves Novartis gene therapy for rare genetic disorder

Novartis shares are on the rise after the FDA approved the company's gene therapy drug. It's priced at $2.1 million total over five years. CNBC's Meg Tirrell reports.

Recent Videos

Featured Partners

image beaconimage beaconimage beacon